| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date | |
|---|
IGC | HLTH | | | RGO 2020-1 (USD 2,000m) | Regeneron Pharmaceuticals Inc | | USOA | Aug 7, 2020 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| GNQ | 4,793.000 | 57 | Feb-19 | So. Pmrihaoip | Lxx3 | HHH+ | - | Ovmmb | Smo | J+140 f | - | 120 | 1.75% | - | 86.57100 | | VKU | 879.000 | 44 | Apr-46 | Fo. Ufrlmnoll | Ycc3 | OOO+ | - | Rwxwh | Rkh | V+180 v | - | 160 | 2.80% | - | 39.47300 |
Tranche Comments 10 wy: Book size: 8512; First Pay: 2021-03-15; Registration: Mapnphauaq; Comments: UZ$1.25fx 1.75% wix 10ib (9/15/30) oc 99.898, izp 1.761%. N+120fi. ZGG N+20fi;
30 kq: Book size: 8434; First Pay: 2021-03-15; Registration: Pfhqfefofc; Comments: LL$750f 2.80% wmg 30je (9/15/50) no 99.715, jsp 2.814%. E+160xm. BQJ E+25xm; Use of Proceeds Ikyhv aemxmhyowyr kahyx |
|
